首页 | 本学科首页   官方微博 | 高级检索  
     


t(11;18)(q21;q21) may delineate a spectrum of diffuse small B-cell lymphoma with extranodal involvement
Authors:Dominique Leroux,Paule Seit  ,Josette Hillion,Fran  ois le Marc'hadour,Brigitte P  gouri  -Bandelier,Marie-Christine Jacob,Christian-Jacques Larsen,Jean-Jacques Sotto
Affiliation:Dominique Leroux,Paule Seité,Josette Hillion,François le Marc'hadour,Brigitte Pégourié-Bandelier,Marie-Christine Jacob,Christian-Jacques Larsen,Jean-Jacques Sotto
Abstract:We describe a patient with stage IV non-Hodgkin's lymphoma (NHL) and a t(11;18)(q21;q21) translocation. He presented with a gastric small B-cell lymphocytic lymphoma, expressing IgAL immunoglobulins without expression of CD10, CD5, and CD23 antigens. The lymphoma was the final development of a 6-year history of a monoclonal IgAL increase complicated by severe renal failure due to membranoproliferative glomerulonephritis. The clinical, histological, immunologic, and cytogenetic features of this patient are very similar to those observed in the five other patients with t(11;18) reported to date. This translocation therefore seems to delineate a new subtype of diffuse small B-cell lymphoma with involvement of mucosal sites. Involvement of the BCL2 oncogene on 18q21 could not be detected using molecular techniques with 5′ as well as 3′ BCL2 probes, indicating that other, so far unknown, genes relevant to lymphoid differentiation could be located in 18q21 and 11q21. © 1993 Wiley-Liss, Inc.
Keywords:
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号